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Background: Apolipoprotein B (apoB) is an excellent risk predictor for cardiovascular events, but little is known about the intestinal apoB48 
subtype compared with the hepatic apoB100 subtype. Coronary artery calcium (CAC) is an extremely specific tool to quantify subclinical 
atherosclerosis. This study aimed to evaluate the association between apoB subtypes and CAC.
methods: We prospectively enrolled intermediate-risk, asymptomatic subjects and measured lipid biomarkers and CAC, from which we calculated 
age/gender/ethnicity-specific population percentile from the Multi-Ethnic Study of Atherosclerosis (MESA). MESA percentile >75th, suggesting 
relatively advanced atherosclerosis, was used to evaluate associations with lipid indices. We performed multivariate analysis (adjusted for smoking, 
hypertension, diabetes and statin use) to determine odds ratio for MESA > 75%.
results: From 71 patients (mean 63.3 years, 96% men) with mean Framingham Risk Score of 14%, 20 (28.2%) had MESA > 75%. ApoB100 was 
found to have the highest association with MESA > 75% (OR 1.53, 95% CI 1.063-2.21, p=0.022) (Figure). Other lipid markers, except for total apoB, 
were not found to be significant independent risk factors.
conclusions: In this group of intermediate risk patients, increasing apoB100 is predictive of CAC > 75th MESA percentile. Future studies are 
necessary to determine whether apoB100 can improve cardiovascular risk prediction models.
